Deals

Dollar sign on digital background
Biotech

Lilly pens $1.3B pact with Superluminal to work on GPCR drugs

Having backed Superluminal Medicines’ series A last year, Eli Lilly has now signed a $1.3 billion pact with the G protein-coupled receptor biotech.
James Waldron Aug 14, 2025 9:45am
Stock exchange concept

Sarepta sells 9M Arrowhead shares for $174M cash

Aug 13, 2025 5:44pm
Kumquats

Bayer picks Kumquat for $1.3B KRAS collaboration

Aug 12, 2025 6:29am
Aerial view of karst mountains and sky clouds natural landscape at sunrise in Guilin China

Expedition inks $645M Fosun deal to bring China asset to US

Aug 11, 2025 11:06am
Bicycle bike ride travel

Bicycle lays off staff as Genentech rides away from R&D pact

Aug 8, 2025 8:50am
illustration of two arrows going in opposite directions

Ipsen hands back Sutro's ROR1 ADC at center of $875M deal

Aug 8, 2025 6:15am